|
US5204252A
(en)
*
|
1989-02-08 |
1993-04-20 |
Henkel Research Corporation |
Candida tropicalis transformation system
|
|
MY106504A
(en)
*
|
1990-07-13 |
1995-06-30 |
Transkaryotic Therapies Inc |
Library screening method.
|
|
WO1992013951A1
(en)
*
|
1991-02-04 |
1992-08-20 |
The Salk Institute Biotechnology/Industrial Associates, Inc. |
Production of human serum albumin in methylotrophic yeast cells
|
|
JP3811186B2
(ja)
*
|
1994-10-18 |
2006-08-16 |
コーバス インターナショナル, インコーポレイテッド |
線虫から抽出されるセリンプロテアーゼ阻害剤および抗凝固性タンパク質
|
|
US5872098A
(en)
*
|
1995-06-05 |
1999-02-16 |
Corvas International, Inc. |
Nematode-extracted anticoagulant protein
|
|
US5866542A
(en)
*
|
1994-10-18 |
1999-02-02 |
Corvas International, Inc. |
Nematode-extracted anticoagulant protein
|
|
US5945275A
(en)
*
|
1994-10-18 |
1999-08-31 |
Corvas International, Inc. |
Nematode-extracted anticoagulant protein
|
|
US5866543A
(en)
*
|
1995-06-05 |
1999-02-02 |
Corvas International, Inc. |
Nematode-extracted anticoagulant protein
|
|
US5863894A
(en)
*
|
1995-06-05 |
1999-01-26 |
Corvas International, Inc. |
Nematode-extracted anticoagulant protein
|
|
CA2202351A1
(en)
*
|
1994-10-18 |
1996-04-25 |
George Phillip Vlasuk |
Nematode-extracted serine protease inhibitors and anticoagulant proteins
|
|
MX9605082A
(es)
|
1996-10-24 |
1998-04-30 |
Univ Autonoma De Nuevo Leon |
Levaduras metilotroficas modificadas geneticamente para la produccion y secrecion de hormona de crecimiento humano.
|
|
JP2003507006A
(ja)
|
1999-05-20 |
2003-02-25 |
サイオス,インコーポレーテッド |
血管内皮増殖因子改変体
|
|
EP1183357A2
(en)
*
|
1999-05-20 |
2002-03-06 |
Scios Inc. |
Vascular endothelial growth factor dimers
|
|
US6261820B1
(en)
*
|
1999-10-01 |
2001-07-17 |
Amgen Inc. |
Fibronolytically active polypeptide
|
|
US6440414B1
(en)
*
|
1999-10-01 |
2002-08-27 |
Amgen Inc. |
Pharmaceutical compositions of fibrinolytic agent
|
|
US7033776B2
(en)
*
|
1999-12-17 |
2006-04-25 |
Amgen Inc. |
Method for treatment of indwelling catheter occlusion using fibrinolytic metalloproteinases
|
|
AU2001257002A1
(en)
*
|
2000-04-10 |
2001-10-23 |
Cubist Pharmaceuticals, Inc. |
Positive selection method, compounds, host cells and uses thereof
|
|
US7449308B2
(en)
|
2000-06-28 |
2008-11-11 |
Glycofi, Inc. |
Combinatorial DNA library for producing modified N-glycans in lower eukaryotes
|
|
US7625756B2
(en)
|
2000-06-28 |
2009-12-01 |
GycoFi, Inc. |
Expression of class 2 mannosidase and class III mannosidase in lower eukaryotic cells
|
|
US8697394B2
(en)
*
|
2000-06-28 |
2014-04-15 |
Glycofi, Inc. |
Production of modified glycoproteins having multiple antennary structures
|
|
US7598055B2
(en)
*
|
2000-06-28 |
2009-10-06 |
Glycofi, Inc. |
N-acetylglucosaminyltransferase III expression in lower eukaryotes
|
|
US7863020B2
(en)
*
|
2000-06-28 |
2011-01-04 |
Glycofi, Inc. |
Production of sialylated N-glycans in lower eukaryotes
|
|
JP2004501642A
(ja)
|
2000-06-28 |
2004-01-22 |
グライコフィ, インコーポレイテッド |
改変された糖タンパク質を生成するための方法
|
|
MXPA02012688A
(es)
|
2000-06-30 |
2004-09-10 |
Flanders Interuniversity Inst |
Modificacion de glicosilacion de proteina en pichia pastoris.
|
|
EP2022799A2
(en)
|
2001-11-16 |
2009-02-11 |
Biogen Idec Inc. |
Polycistronic expression of antibodies
|
|
IL165717A0
(en)
|
2002-06-26 |
2006-01-15 |
Flanders Interuniversity Inst |
A strain of methylotrophic yeast for producing proteins
|
|
US7118901B2
(en)
*
|
2002-12-18 |
2006-10-10 |
Roche Diagnostics Operations, Inc. |
Recombinant bovine pancreatic desoxyribonuclease I with high specific activity
|
|
ATE387494T1
(de)
*
|
2002-12-20 |
2008-03-15 |
Hoffmann La Roche |
Hitzelabile desoxyribonuklease i-varianten
|
|
US7332299B2
(en)
*
|
2003-02-20 |
2008-02-19 |
Glycofi, Inc. |
Endomannosidases in the modification of glycoproteins in eukaryotes
|
|
EP1460425A1
(en)
*
|
2003-03-17 |
2004-09-22 |
Boehringer Mannheim Gmbh |
Deglycosylated enzymes for conjugates
|
|
CA2486195C
(en)
*
|
2003-12-05 |
2012-03-06 |
Stephan Glaser |
Recombinantly expressed carboxypeptidase b and purification thereof
|
|
US7588745B2
(en)
*
|
2004-04-13 |
2009-09-15 |
Si Options, Llc |
Silicon-containing products
|
|
MX2008003362A
(es)
*
|
2005-09-14 |
2008-03-25 |
Sanofi Aventis Deutschland |
Escision de precursores de insulinas mediante una variante de tripsina.
|
|
CN101535340B
(zh)
*
|
2006-05-19 |
2013-05-01 |
格利科菲公司 |
促红细胞生成素组合物
|
|
KR102069498B1
(ko)
|
2007-09-28 |
2020-01-23 |
포톨라 파마슈티컬스, 인코포레이티드 |
인자 Xa 저해제에 대한 안티도트 및 그것을 사용하는 방법
|
|
US8067339B2
(en)
|
2008-07-09 |
2011-11-29 |
Merck Sharp & Dohme Corp. |
Surface display of whole antibodies in eukaryotes
|
|
CA2733567A1
(en)
|
2008-08-12 |
2010-02-18 |
Glycofi, Inc. |
Improved vectors and yeast strains for protein production: ca2+ atpase overexpression
|
|
CN102232085A
(zh)
|
2008-09-26 |
2011-11-02 |
Ambrx公司 |
修饰的动物促红细胞生成素多肽和其用途
|
|
PL3604510T3
(pl)
|
2009-03-30 |
2025-07-28 |
Alexion Pharmaceuticals, Inc. |
Antidota na inhibitory czynnika xa i sposoby ich stosowania
|
|
CN102625712B
(zh)
|
2009-07-15 |
2017-07-25 |
博尔托拉制药公司 |
用于因子xa抑制剂的解毒剂的单位剂量制剂及其使用方法
|
|
RU2012120102A
(ru)
|
2009-10-16 |
2013-12-10 |
Мерк Шарп И Доум Корп. |
Способ получения белков в pichia pastoris, у которых отсутствует поддающаяся обнаружению перекрестная связующая активность по отношению к антителам против антигенов клетки-хозяина
|
|
WO2011053541A1
(en)
|
2009-10-30 |
2011-05-05 |
Merck Sharp & Dohme Corp. |
Methods for the production of recombinant proteins with improved secretion efficiencies
|
|
MX2012009802A
(es)
|
2010-02-24 |
2012-09-12 |
Merck Sharp & Dohme |
Metodo para incrementar la ocupacion del sitio de n-glucosilacion en glucoproteinas terapeuticas producidas en pichia pastoris.
|
|
HRP20211873T1
(hr)
|
2011-05-20 |
2022-03-04 |
H. Lundbeck A/S |
Proizvodnja visoke čistoće proteina s više podjedinica kao što su protutijela u transformiranim mikrobima kao što je pichia pastoris
|
|
WO2013028635A1
(en)
|
2011-08-19 |
2013-02-28 |
Alderbio Holdings Llc |
Multi-copy strategy for high-titer and high-purity production of multi-subunit proteins such as a antibodies in transformed microbes such as pichia pastoris
|
|
HK1205188A1
(en)
|
2012-02-14 |
2015-12-11 |
Portola Pharmaceuticals, Inc. |
Process for making recombinant antidote to factor xa inhibitor
|
|
EP2925345B1
(en)
|
2012-12-03 |
2018-09-05 |
Merck Sharp & Dohme Corp. |
Method for making o-glycosylated carboxy terminal portion (ctp) peptide-based insulin and insulin analogues
|
|
WO2014138188A1
(en)
|
2013-03-07 |
2014-09-12 |
The General Hospital Corporation |
Human ctla4 mutants and use thereof
|
|
CA2905180C
(en)
|
2013-03-15 |
2023-03-07 |
Alder Biopharmaceuticals, Inc. |
Temperature shift for high yield expression of polypeptides in yeast and other transformed cells
|
|
EP3754012A1
(en)
|
2013-03-15 |
2020-12-23 |
Alder Biopharmaceuticals, Inc. |
Antibody purification and purity monitoring
|
|
EP3024323B1
(en)
|
2013-07-24 |
2022-10-19 |
Streck, Inc. |
Compositions and methods for stabilizing circulating tumor cells
|
|
US11168351B2
(en)
|
2015-03-05 |
2021-11-09 |
Streck, Inc. |
Stabilization of nucleic acids in urine
|
|
WO2017011275A1
(en)
|
2015-07-10 |
2017-01-19 |
Nersissian Aram M |
Factor viii protein compositions and methods of treating hemophilia a
|
|
AU2016335699A1
(en)
|
2015-10-09 |
2018-05-24 |
Genzyme Corporation |
Early post-transfection isolation of cells (EPIC) for biologics production
|
|
US20170145475A1
(en)
|
2015-11-20 |
2017-05-25 |
Streck, Inc. |
Single spin process for blood plasma separation and plasma composition including preservative
|
|
WO2018022991A1
(en)
|
2016-07-29 |
2018-02-01 |
Streck, Inc. |
Suspension composition for hematology analysis control
|
|
SG10202103545PA
(en)
|
2016-10-07 |
2021-05-28 |
Genzyme Corp |
Early post-transfection isolation of cells (epic) for biologics production
|
|
WO2019079743A1
(en)
|
2017-10-19 |
2019-04-25 |
Streck, Inc. |
COMPOSITIONS FOR HEMOLYSIS AND REGULATION OF COAGULATION AND STABILIZATION OF EXTRACELLULAR VESICLES
|
|
EP3505181B1
(en)
|
2017-12-28 |
2021-07-07 |
Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center |
Preparation of enzyme replacement therapy for mucopolysaccharidosis iiid
|
|
WO2020172344A1
(en)
|
2019-02-19 |
2020-08-27 |
The Regents Of The University Of Colorado, A Body Corporate |
Bispecific immunotoxins targeting human cd25+ccr4+ tumors and regulatory t-cells
|
|
EP4010379B1
(en)
|
2019-08-08 |
2025-04-02 |
Alexion Pharmaceuticals, Inc. |
Compositions and methods for preparing factor xa and derivatives
|
|
NL2031833B1
(en)
|
2022-05-11 |
2023-11-17 |
Univ Leiden |
Immunotherapeutic compositions and adjuvants
|
|
WO2024032891A1
(en)
|
2022-08-11 |
2024-02-15 |
Vib Vzw |
Glyco-engineered yeast for therapeutic protein production
|
|
WO2025196308A1
(en)
|
2024-03-22 |
2025-09-25 |
Vib Vzw |
Means and methods for displaying fc-containing proteins on cells and selection thereof
|